As shown in Table 1, these features are clearly different than what has been observed in other PCD patients with identified mutations in ODAD1, with all other subjects having low levels of nNO and recurrent otitis media, and most having neonatal respiratory distress, bronchiectasis, sinusitis, respiratory bacterial pathogens, and low FEV1 (% predicted). Here, ODAD1 is linked to bronchiectasis.